Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 693-703

  Benavides, Fernando ^a   Starost, Matthew F ^b   Flores, Mónica ^a   Gimenez Conti, Irma B ^a   Guénet, Jean Louis ^c   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Sci Park Dept of Vet Sciences   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME DEFICIENCY; EPIDERMIS; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HISTOPATHOLOGY; MALE; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036968842     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64225-3     Document Type: Article

References (54)

1. Yamanishi K: Gene-knockout mice with abnormal epidermal and hair follicular development. J Dermatol Sci 1998, 18:75-89
2. Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models on Biomedical Tools. Boca Raton, CRC Press, Inc., 1994
3. Sundberg JP, King Jr LE: Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 1996, 106:368-376
4. Benavides F, Giordano M, Fiette L, Bueno Brunialti AL, Martin Palenzuela N, Vanzulli S, Baldi P, Schmidt R, Dosne Pasqualini C, Guénet J: Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency. Immunogenetics 1999, 49:413-419
5. Benavides F, Venable A, Poetschke Klug H, Glasscock E, Rudensky A, Martin Palenzuela N, Guénet J-L, Richie E, Conti CJ: The CD4 T cell deficient mouse mutation. Nackt (nkt) involves a deletion in the cathepsin L gene (Ctsl). Immunogenetics 2001, 53:233-242
6. Pilz A, Woodward K, Povey S, Abbott C: Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. Genomics 1995, 25:139-149
7. Deussing J, Roth W, Rommerskirch W, Wiederanders B, von Figura K, Peters C: The genes of the lysosomal cysteine proteinases cathepsin B, H, L and S map to different mouse chromosomes. Mamm Genome 1997, 8:241-245
8. Chauhan SS, Popescu NC, Ray D, Fleischmann R, Gottesman MM, Troen BR: Cloning, genomic organization, and chromosomal localization of human cathepsin L. J Biol Chem 1993, 268:1039-1045
9. Riese RJ, Chapman HA: Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 2000, 12:107-113
10. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453
11. Green EL: The genetics of a new hair deficiency, furless. J Hered 1954, 45:115-118
12. Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, Von Figura K, Paus R, Peters C: Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. EMBO J 2000, 14:2075-2086
13. Sundberg JP, King LE: Skin and its appendages: normal anatomy and pathology of spontaneous, transgenic, and targeted mouse mutations. Pathology of Genetically Engineered Mice. Edited by JM Ward, JF Mahler, RR Maronpot, JP Sundberg. Ames, Iowa State University Press, 1999, pp 183-215
14. Sundberg JP, Boggess D: Systematic Approach to Evaluation of Mouse Mutations. Boca Raton, CRC Press, Inc., 2000
15. Paus R, Muller-Rover S, Van Der Veen C, Maurer M, Eichmuller S, Ling G, Hofmann U, Foitzik K, Mecklenburg L, Handjiski B: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999, 113:523-532
16. Rodriguez-Puebla ML, LaCava M, Miliani De Marval PL, Jorcano JL, Richie ER, Conti CJ: Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Am J Pathol 2000, 157:1039-1050
17. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH: Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 1984, 259:8037-8040
18. Mahooti S, Graesser D, Patil S, Newman P, Duncan G, Mak T, Madri JA: PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol 2000, 157:75-81
19. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP: Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000, 115:1072-1081
20. Miliani De Marval PL, Gimenez-Conti IB, LaCava M, Martinez LA, Conti CJ, Rodriguez-Puebla ML: Transgenic expression of cyclindependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. Am J Pathol 2001, 159:369-379
21. Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL: Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 2000, 60:3088-3095
22. Fuchs E: Keratins and the skin. Annu Rev Cell Dev Biol 1995, 11:123-153
23. Rothnagel JA, Seki T, Ogo M, Longley MA, Wojcik SM, Bundman DS, Bickenbach JR, Roop DR: The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis. Differentiation 1999, 65:119-130
24. Li ER, Owens DM, Djian P, Watt FM: Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp Dermatol 2000, 9:431-438
25. Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494
26. Sundberg JP, Cordy WR, King Jr LE: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994, 102:847-856
27. Shultz LD, Heiniger HJ, Eicher EM: Immunopathology of streaker mice: a remutation to nude in the AKR/J strain. Animal Models of Comparative and Developmental Aspects of Immunity and Disease. Edited by ME Gershwing, EL Cooper. New York, Pergamon Press, 1978, pp 211-222
28. Schorpp M, Hofman M, Dear TN, Boehm T: Characterization of mouse and human nude genes. Immunogenetics 1997, 46:509-515
29. Davisson MT, Cook SA, Johonson KR, Eicher EM: Balding: a new mutation on mouse chromosome 18 causing hair loss and immunological defects. J Hered 1994, 85:134-136
30. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR: Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997, 137:1091-102
31. Pelsue SC, Schweitzer PA, Schweitzer IB, Christianson SW, Gott B, Sundberg JP, Beamer WG, Shultz LD: Lymphadenopathy, elevated serum IgE levels, autoimmunity, and mast cell accumulation in flaky skin mutant mice. Eur J Immunol 1998, 28:1379-1388
32. Panteleyev AA, Botchkareva NV, Sundberg JP, Christiano AM, Paus R: The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol 1999, 155:159-171
33. Sundberg JP, King Jr LE: Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 1996, 106:368-376
34. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994, 8:399-413
35. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376:71-80
36. Nakagawa T, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastma SE, Howard ED, Clarke SRM, Rosloniec EF, Elliott EA, Rudensky AY: Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217
37. Paus R: Principles of hair cycle control. J Dermatol 1998, 25:793-802
38. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R: Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997, 151:1601-1617
39. Philpott MF, Paus R: Principles of hair follicle morphogenesis. Molecular Biology of Skin Appendages Morphogenesis. Edited by CM Chuong. Austin, RG Landes Company, 1998, pp 75-110
40. Pearton DJ, Nirunsuksiri W, Rehemtulla A, Lewis SP, Presland RB, Dale BA: Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp Dermatol 2001, 10:193-203
41. Horikoshi T, Arany I, Rajaraman S, Chen SH, Brysk H, Lei G, Tyring SK, Brysk MM: Isoforms of cathepsin D and human epidermal differentiation. Biochimie 1998, 80:605-612
42. Kawada A, Hara K, Kominami E, Hiruma M, Noguchi H, Ishibashi A: Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 1997, 289:87-93
43. Zwad O, Kubler B, Roth W, Scharf JG, Saftig P, Peters C, Braulke T: Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. FEBS Lett 2002, 510:211-215
44. Kuechle MK, Thulin CD, Presland RB, Dale BA: Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J Invest Dermatol 1999, 112:843-852
45. Presland RB, Kimball JR, Kautsky MB, Lewis SP, Lo CY, Dale BA: Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 1997, 108:170-178
46. Kawada A, Hara K, Hiruma M, Noguchi H, Ishibashi A: Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates. J Biochem 1995, 118:332-337
47. Ishida-Yamamoto A, Eady RA, Underwood RA, Dale BA, Holbrook KA: Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis). Br J Dermatol 1994, 131:767-779
48. Reichelt J, Bussow H, Grund C, Magin TM: Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol Biol Cell 2001, 12:1557-1568
49. Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB: The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol 1998, 110:951-957
50. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan L, Roberts E, Woods CG, Markham A, Wong M, Widmer R, Ghaffar KA, Pemberton M, Hussein IR, Temtamy SA, Davies R, Read AP, Sloan P, Dixon MJ, Thakker NS: Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999, 23:421-424
51. Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, Zlotogorski A, Shapira L, Soskolne WA: Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C. J Med Genet 2000, 37:88-94
52. Pham CT, Ley TJ: Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999, 96:8627-8632
53. Jaqueti G, Requena L, Sanche Zyus E: Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol 2000, 22:108-118
54. Prouty SM, Lawrence L, Stenn KS: Fibroblast-dependent induction of a murine skin lesion similar to human nevus sebaceus of Jadassohn. Lab Invest 1997, 76:179-189